Establishing a consortium to enhance health equity for Hispanic Puerto Ricans
Official title: Puerto Rico Racial & Ethnic Minority Acceleration Consortium for Health Equity (PR-REACH)
Funded at University of Puerto Rico Med Sciences · NIH-11234165 · Data updated 2026-11-12
This study is all about listening to Hispanic Puerto Ricans to understand their experiences and needs with FDA-approved medications, so we can work together to improve their health and make sure everyone gets the care they deserve.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Puerto Rico Med Sciences NIH-funded |
| Lab location | 1 site (San Juan, United States) |
| Project start | June 1, 2023 |
| Project end | May 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $100,000 |
| NIH project number | 3U01FD007977-02S3 |
| Project ID | NIH-11234165 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are Hispanic Puerto Ricans who have experiences or unmet needs related to FDA-approved treatments.
✕Less likely to help
Patients outside of the Hispanic Puerto Rican community may not receive direct benefits from this research.
What this research studies
This research aims to create the Puerto Rico Racial & Ethnic Minority Acceleration Consortium for Health Equity (PR-REACH), which will focus on amplifying the voices of Hispanic Puerto Ricans regarding their experiences and unmet needs related to FDA-approved medications. The consortium will work to gather insights from this underrepresented group and collaborate with the FDA to improve health outcomes. Additionally, it will include a training component to educate researchers, patients, and healthcare providers about these issues. By leveraging advanced data analysis techniques, the project seeks to better understand and address the health disparities faced by Puerto Ricans.
Why it matters
Potential benefit: If successful, this research could lead to improved access to and outcomes from FDA-approved medications for Hispanic Puerto Ricans.
How similar studies have gone: While the approach of establishing a consortium for health equity is innovative, similar initiatives have shown promise in addressing health disparities in other minority populations.
Where this research is happening
-
University of Puerto Rico Med Sciences
San Juan, United States Active
Researchers
- Principal investigator: Santiago, Darlene I — University of Puerto Rico Med Sciences
- Study coordinator: Santiago, Darlene I
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.